Get startedLog in
    Picture of Cerevel Therapeutics Holdings logo

    CERE — Cerevel Therapeutics Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Abbvie eyes selling at least $13 billion of bonds to fund M&A, Bloomberg reports

    Picture of Cerevel Therapeutics Holdings logoCerevel Therapeutics Holdings
    21/02/2024 23:02
    Feb 21 (Reuters) - AbbVie  ABBV.N  is looking to sell at
least $13 billion of corporate bonds to help fund its
acquisitions of ImmunoGen and Cerevel Therapeutics  CERE.O ,
Bloomberg news reported on Wednesday, citing people with
knowledge of the matter.

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))

    Recent news on Cerevel Therapeutics Holdings

    See all news